Storia in 2 fonti

Wellness Briefing: The peptide pipeline gets new legal momentum, plus news

Glossy checked in with leaders in the peptide space to unpack the results of last week’s FDA advisory committee meetings.

Raccontata da

glossy.co

fiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

glossy.coStai leggendo1 mese fa

Wellness Briefing: The peptide pipeline gets new legal momentum, plus news

FDA committee voted six peptides toward 503A approval (February 2027), enabling compounding pharmacies to sell legally and giving telehealth platforms an 8-month window to scale. Shift from consumer-led to clinician-led access risks cutting direct-to-consumer channels.

originale

fiercepharma.com1 mese fa

Psychedelics, peptides and GLP-1s

Big Pharma moves into psychedelics via acquisitions; Novo sues Eli Lilly over false GLP-1 obesity ads. Pharma consolidation and regulatory shifts in obesity therapeutics redefine competitive dynamics and compliance infrastructure for biotech IT operations.

Timeline cronologica

mercoledì 29 luglio 2026·glossy.co
Wellness Briefing: The peptide pipeline gets new legal momentum, plus news
Glossy checked in with leaders in the peptide space to unpack the results of last week’s FDA advisory committee meetings.
venerdì 31 luglio 2026·fiercepharma.com
Psychedelics, peptides and GLP-1s
Is biotech taking a trip to the world of psychedelic drugs? Why is Novo Nordisk going after Eli Lilly’s Zepbound ads? | This week on “The Top Line,” Fierce’s Zoey Becker, Will…